WO2011051967A3 - Compositions pharmaceutiques contenant du mycophénolate et leurs procédés de préparation - Google Patents
Compositions pharmaceutiques contenant du mycophénolate et leurs procédés de préparation Download PDFInfo
- Publication number
- WO2011051967A3 WO2011051967A3 PCT/IN2010/000688 IN2010000688W WO2011051967A3 WO 2011051967 A3 WO2011051967 A3 WO 2011051967A3 IN 2010000688 W IN2010000688 W IN 2010000688W WO 2011051967 A3 WO2011051967 A3 WO 2011051967A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical compositions
- mycophenolate
- preparing
- processes
- core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne un procédé de préparation de compositions pharmaceutiques de mycophénolate gastrorésistantes, un sel ou un promédicament de celles-ci, lesdites compositions étant préparées pour libérer au moins environ 10% en poids de mycophénolate dans un milieu acide de 0,1 N HCl, pH 1,2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1706/MUM/2009 | 2009-10-23 | ||
IN1706MU2009 | 2009-10-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011051967A2 WO2011051967A2 (fr) | 2011-05-05 |
WO2011051967A3 true WO2011051967A3 (fr) | 2011-06-16 |
Family
ID=43922727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2010/000688 WO2011051967A2 (fr) | 2009-10-23 | 2010-10-22 | Compositions pharmaceutiques contenant du mycophénolate et leurs procédés de préparation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011051967A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016023082A1 (fr) | 2014-08-12 | 2016-02-18 | Monash University | Promédicaments de transport vers le système lymphatique |
CN118063537A (zh) | 2015-09-08 | 2024-05-24 | 莫纳什大学 | 定向淋巴的前药 |
US11883497B2 (en) | 2017-08-29 | 2024-01-30 | Puretech Lyt, Inc. | Lymphatic system-directing lipid prodrugs |
US11304954B2 (en) | 2017-12-19 | 2022-04-19 | Puretech Lyt, Inc. | Lipid prodrugs of mycophenolic acid and uses thereof |
WO2019126378A1 (fr) * | 2017-12-19 | 2019-06-27 | Ariya Therapeutics, Inc. | Promédicaments lipidiques d'acide mycophénolique et leurs utilisations |
US11608345B1 (en) | 2017-12-19 | 2023-03-21 | Puretech Lyt, Inc. | Lipid prodrugs of rapamycin and its analogs and uses thereof |
IL295362A (en) | 2020-02-05 | 2022-10-01 | Puretech Lyt Inc | Lipid drug inhibitors of neurosteroids |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997038689A2 (fr) * | 1996-04-12 | 1997-10-23 | Novartis Ag | Compositions pharmaceutiques a delitage enterique et a base de mycophenolate |
WO2003032978A1 (fr) * | 2001-10-17 | 2003-04-24 | Novartis Ag | Compositions pharmaceutiques comprenant de l'acide mycophenolique ou un sel mycophenolate |
WO2009110005A2 (fr) * | 2008-03-05 | 2009-09-11 | Panacea Biotec Limited | Compositions pharmaceutiques à libération modifiée comprenant du mycophénolate et procédés pour celles-ci |
-
2010
- 2010-10-22 WO PCT/IN2010/000688 patent/WO2011051967A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997038689A2 (fr) * | 1996-04-12 | 1997-10-23 | Novartis Ag | Compositions pharmaceutiques a delitage enterique et a base de mycophenolate |
US6306900B1 (en) * | 1996-04-12 | 2001-10-23 | Novartis Ag | Enteric coated pharmaceutical compositions |
WO2003032978A1 (fr) * | 2001-10-17 | 2003-04-24 | Novartis Ag | Compositions pharmaceutiques comprenant de l'acide mycophenolique ou un sel mycophenolate |
WO2009110005A2 (fr) * | 2008-03-05 | 2009-09-11 | Panacea Biotec Limited | Compositions pharmaceutiques à libération modifiée comprenant du mycophénolate et procédés pour celles-ci |
Also Published As
Publication number | Publication date |
---|---|
WO2011051967A2 (fr) | 2011-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011051967A3 (fr) | Compositions pharmaceutiques contenant du mycophénolate et leurs procédés de préparation | |
WO2011060304A3 (fr) | Laveurs d'oxygène, compositions comprenant les laveurs, et articles réalisés à partir des compositions | |
EP2474539A4 (fr) | Composé diépoxy, son procédé de production et composition contenant le composé diépoxy | |
WO2010042951A3 (fr) | Revêtements antireflet comprenant des couches ordonnées de nanocâbles et procédés de fabrication et d'utilisation de ceux-ci | |
WO2014093747A3 (fr) | Compositions antitranspirantes et déodorantes | |
WO2009135646A3 (fr) | Compositions pharmaceutiques stables et procédés de préparation desdites compositions adaptés à l’échelle industrielle | |
EP2251038A4 (fr) | Dispersion solide, compositions pharmaceutiques comprenant celle-ci, et procédés de production associés | |
IL216826A0 (en) | Pyridil-triazine derivatives, compositions comprising the same and processes for producing the same | |
WO2011130671A3 (fr) | Compositions de revêtement pour des articles d'emballage et procédés de revêtement | |
IL211541A0 (en) | Co-crystal compositions, methods of producing the same and uses thereof | |
WO2013050337A3 (fr) | Composition de revêtement et revêtement antireflet préparé à partir de celle-ci | |
IL215059A (en) | Liposome preparation that includes an arboline and a process for its preparation | |
EP2281782A4 (fr) | Poudre d'alumine, son procédé de fabrication et compositions de résine la contenant | |
WO2010151541A8 (fr) | Forme polymorphe d d'acetate de bazedoxifene et leurs procedes de preparation | |
IL210549A (en) | Pipedrine - Quinocosalin-Mediated Conjugated Drugs | |
WO2010118866A8 (fr) | Composition contenant du trehalulose, sa preparation et son utilisation | |
WO2014016848A3 (fr) | Formes solides d'inhibiteurs de tyrosine kinase, procédé pour leur préparation et leur composition pharmaceutique | |
IL213324A (en) | Beverages and barley plant compositions, and methods for making barley beverages or compositions | |
IL214962A0 (en) | Muscarinic agonist compounds, compositions comprising the same, methods of preparing the same and uses thereof | |
EP2340297A4 (fr) | Composition, son procédé de fabrication et son utilisation | |
WO2013050022A3 (fr) | Matières de revêtement pour des moules de coulée et des noyaux inorganiques, contenant des sels, et leur utilisation | |
EP2532714A4 (fr) | Composite organique-inorganique, composition pour la formation d'un composite organique-inorganique, et encre | |
EP2322574A4 (fr) | Résine ionomère, compositions de résine la contenant et leurs utilisations | |
WO2010065586A3 (fr) | Préparation de capécitabine | |
EP3722277A3 (fr) | 3 embouts pour des agents arni utilisés dans l'arn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10826235 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10826235 Country of ref document: EP Kind code of ref document: A2 |